Call Options

17 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$76.67 - $87.62 $26.2 Million - $30 Million
341,900 New
341,900 $26.6 Million
Q1 2022

May 17, 2022

SELL
$55.72 - $67.12 $24.8 Million - $29.9 Million
-445,672 Reduced 42.68%
598,600 $39.7 Million
Q4 2021

Feb 15, 2022

SELL
$54.02 - $63.83 $20.4 Million - $24 Million
-376,716 Reduced 26.51%
1,044,272 $60.8 Million
Q3 2021

Nov 16, 2021

BUY
$55.56 - $60.79 $48 Million - $52.5 Million
864,088 Added 155.16%
1,420,988 $85.3 Million
Q2 2021

Aug 16, 2021

SELL
$48.42 - $60.18 $6.86 Million - $8.52 Million
-141,600 Reduced 20.27%
556,900 $33.4 Million
Q1 2021

May 18, 2021

SELL
$47.16 - $54.44 $11.7 Million - $13.6 Million
-249,100 Reduced 26.29%
698,500 $34.7 Million
Q4 2020

Feb 17, 2021

BUY
$48.52 - $58.02 $2.34 Million - $2.8 Million
48,300 Added 5.37%
947,600 $47.4 Million
Q3 2020

Nov 17, 2020

BUY
$53.07 - $61.1 $6.33 Million - $7.28 Million
119,200 Added 15.28%
899,300 $49.3 Million
Q2 2020

Aug 17, 2020

BUY
$43.1 - $55.31 $18 Million - $23 Million
416,600 Added 114.61%
780,100 $41.3 Million
Q1 2020

May 15, 2020

BUY
$37.79 - $51.33 $8.88 Million - $12.1 Million
235,100 Added 183.1%
363,500 $16.2 Million
Q4 2019

Feb 14, 2020

SELL
$42.46 - $50.46 $2.11 Million - $2.5 Million
-49,600 Reduced 27.87%
128,400 $6.4 Million
Q3 2019

Nov 14, 2019

BUY
$40.12 - $45.47 $6.91 Million - $7.83 Million
172,200 Added 2968.97%
178,000 $7.93 Million
Q2 2019

Aug 15, 2019

SELL
$37.28 - $41.68 $14,912 - $16,672
-400 Reduced 6.45%
5,800 $239,000
Q1 2019

May 16, 2019

SELL
$35.49 - $43.02 $7,098 - $8,604
-200 Reduced 3.13%
6,200 $251,000
Q4 2018

Feb 15, 2019

SELL
$36.86 - $41.49 $501,296 - $564,264
-13,600 Reduced 68.0%
6,400 $243,000
Q1 2018

May 15, 2018

BUY
$32.97 - $36.63 $293,433 - $326,007
8,900 Added 80.18%
20,000 $699,000
Q3 2017

Nov 14, 2017

BUY
$28.96 - $34.0 $321,456 - $377,400
11,100
11,100 $376,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $206B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.